Dynavax Technologies News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

28.12.21	COVID-19 Vaccine Developed by Biological E Using Dynavax's CpG 1018 Adjuvant Receives India DCGI Approval for Emergency Use (PR Newswire)
14.12.21	Elaine D. Sun Appointed to Dynavax Board of Directors (PR Newswire)
02.12.21	Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
18.11.21	Dynavax to Present at the 4th Annual Evercore Virtual ISI HealthCONx Conference (PR Newswire)
05.11.21	Pre-market Movers: RWLK, OTRK, EVAX, NRXP, PTON… (RTTNews)
03.11.21	Ausblick: Dynavax Technologies präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net)
02.11.21	Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
21.10.21	Scott Myers Appointed to Dynavax Board of Directors and Elected Board Chairman (PR Newswire)
21.10.21	Dynavax to Report Third Quarter 2021 Financial Results and Host Conference Call on November 4, 2021 (PR Newswire)
18.10.21	Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
18.10.21	Pre-market Movers: JCS, VALN, RVNC, HX, AVDL… (RTTNews)
18.10.21	COVID-19 Vaccine Developed by Valneva Using Dynavax's CpG 1018 Adjuvant Meets Both Co-Primary Endpoints in Phase 3 COV-COMPARE Trial (PR Newswire)
04.10.21	Dynavax and U.S. Department of Defense Announce Collaboration to Develop an Adjuvanted Plague Vaccine Using Dynavax's CpG 1018 Adjuvant (PR Newswire)
02.10.21	Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
27.09.21	Dynavax to Present at Upcoming Investment Conferences (PR Newswire)
22.09.21	COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial (PR Newswire)
13.09.21	Pre-market Movers: ITMR, FAMI, VALN, CYRN, LPTX... (RTTNews)
13.09.21	Dynavax Issues Update On CpG 1018 Purchase Orders From Valneva SE - Quick Facts (RTTNews)
13.09.21	Dynavax Provides Update on its COVID-19 Collaboration with Valneva (PR Newswire)
09.09.21	Dynavax to Present at the H.C. Wainwright 23rd Annual Global Investment Conference (PR Newswire)
02.09.21	Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
04.08.21	Dynavax Announces Second Quarter 2021 Financial Results (PR Newswire)
03.08.21	Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
02.08.21	Ausblick: Dynavax Technologies präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net)
21.07.21	Dynavax to Report Second Quarter 2021 Financial Results and Host Conference Call on August 4, 2021 (PR Newswire)
06.07.21	Biological E To Buy Dynavax's CpG 1018 Adjuvant For COVID-19 Vaccine Candidate (RTTNews)
06.07.21	Dynavax and Biological E Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Biological E's COVID-19 Vaccine Candidate (PR Newswire)
02.07.21	Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
30.06.21	Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine Candidate (PR Newswire)
30.06.21	China's Clover In Deal To Use Dynavax's CpG 1018 Adjuvant In COVID-19 Vaccine Candidate (RTTNews)
30.06.21	Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine Candidate (PR Newswire)
30.06.21	Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine Candidate (PR Newswire)
29.06.21	Dynavax Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
06.04.21	Valneva Reports Positive Results From Trial Of COVID-19 Vaccine Candidate Using Dynavax's Adjuvant (RTTNews)
24.03.21	Clover, Dynavax Dose First Patient In Phase 2/3 Trial Of Adjuvanted COVID-19 Vaccine Candidate (RTTNews)
23.02.21	Ausblick: Dynavax Technologies informiert über die jüngsten Quartalsergebnisse (finanzen.net)
02.02.21	ADMS Gets FDA Nod, ARQT Soars On Psoriasis Trial Data, DVAX Catches Eye, PRTA On Watch (RTTNews)
01.02.21	Clover, Dynavax Plan To Initiate Phase 2/3 Efficacy Trial Of Adjuvanted COVID-19 Vaccine Candidate (RTTNews)
16.11.20	BE Begins COVID-19 Vaccine Trial In India Containing Dynavax's CpG 1018 - Quick Facts (RTTNews)
01.11.20	Week Ahead In Pharma: COVID-19 Data Readout, FDA Decisions, CTAD Presentation (RTTNews)
13.10.20	Dynavax: MVC Begins Phase 1 Trial For Adjuvanted Vaccine Candidate To Prevent COVID-19 (RTTNews)
14.09.20	Pre-market Movers In Healthcare Sector: IMMU, SAVA, DVAX, ENLV, VXRT... (RTTNews)
14.09.20	Valneva, Dynavax Reach Commercial Supply Agreement For COVID-19 Vaccine (RTTNews)
14.08.20	Pre-market Movers In Healthcare Sector: TFFP, NVAX, KMDA, PRPO, DVAX... (RTTNews)
13.08.20	Dynavax Gets Funding From Bill & Melinda Gates Foundation To Support Development Of COVID-19 Vaccine (RTTNews)
05.08.20	Ausblick: Dynavax Technologies stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
23.07.20	Dynavax, Medigen Collaborate To Develop Adjuvanted COVID-19 Vaccine Candidate (RTTNews)
21.07.20	Stock Alert: Dynavax Down 12% (RTTNews)
19.06.20	Clover Biopharma Begins Phase 1 Trial For COVID-19 Vaccine - Quick Facts (RTTNews)
13.06.20	Race For COVID-19 Vaccine: Who Are The Key Players? (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	302.80	1.30 %	K V
Alcon	76.88	0.65 %	K V
Sika	218.00	0.37 %	K V
Kuehne+Nagel Int	202.60	-0.20 %	K V
Logitech Intl	78.28	-0.33 %	K V
ABB	49.25	-1.44 %	K V
Holcim	87.68	-1.55 %	K V
Zurich Insur Gr	531.20	-1.63 %	K V
Roche Hldg G	267.20	-1.69 %	K V
UBS Group	29.78	-1.94 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Dynavax Technologies Corp

Aktien Top/Flop

Meistgelesene Nachrichten